載入...
Periodic fasting starves cisplatin‐resistant cancers to death
Treatment of cancers with the cytotoxic agent cisplatin frequently evokes resistance, accompanied by rewiring of metabolic pathways, limiting its clinical use. Recent research by Obrist et al (2018) shows that cisplatin‐resistant growth of lung adenocarcinoma is particularly vulnerable to periodic f...
Na minha lista:
| 發表在: | EMBO J |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley and Sons Inc.
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6043846/ https://ncbi.nlm.nih.gov/pubmed/29875131 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/embj.201899815 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|